Search
Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.
Researchers from Memorial Sloan Kettering Cancer Center (MSK) announced today that the latest results from that follicular lymphoma clinical trial have shown the three-drug combination — rituximab (Rituxan®) and lenalidomide (Revlimid®), along with epcoritamab (Epkinly®) — works better than using the two drugs alone. The findings were presented at the American Society of Hematology Annual Meeting (ASH) on December 7, 2025. The findings were also published in The Lancet.
The preliminary results of our ongoing trial investigating CAR T cell therapy to treat patients with malignant pleural disease, including mesothelioma, show “encouraging clinical outcomes”
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
This new era of cancer research investigates how the disease in certain locations interacts with all the body’s systems. Focusing on cancer’s ecosystem promises to reveal lifesaving insights, especially into metastasis.
Memorial Sloan Kettering social worker Melissa Stewart has been awarded the Assocation of Oncology Social Work (AOSW)’s Dennis Roth Neuro-Oncology Social Worker of the Year for 2010. She will be honored at the AOSW conference in Phoenix, Arizona on May 2, 2010.
Meet Monika Shah, MD, infectious disease specialist at Memorial Sloan Kettering.
Memorial Sloan Kettering Cancer Center has announced the appointment of David R. Jones as Chief of the Thoracic Service in the Department of Surgery, and Charles M. Rudin as Chief of the Thoracic Oncology Service, Division of Solid Tumor Oncology, in the Department of Medicine.
Grief can feel all-consuming, but those intense feelings don’t last forever.
The routine use of epidural analgesia for patients with non-small cell lung cancer who undergo a minimally invasive lobectomy is not warranted.